Search Results: lung disease

Actemra
In 2010, the U.S. Food and Drug Administration (FDA) approved Actemra (tocilizumab) to treat symptoms of rheumatoid arthritis, a condition that affects more than 1.5 million Americans. Upon its approval, the drug showed fewer initial side effects than other treatments—a factor that encouraged doctors to prescribe the drug to their patients. In fact, gross sales for Actemra totaled $1.7 billion in 2016, and (more...)
Cancer drug’s toxicity could cause drug injuries December 9, 2010 We know cancer can be caused by toxic substances such as those found in charred food, certain chemicals, and the ingredients in tobacco products. Patients may expect medications taken for treatment of cancer to be nontoxic. However, AFP reports that in a study of AstraZeneca’s drug Vandetanib, a drug used for treatment (more...)